NAD+ Therapy in Texas — Costs, Clinics, and What to Expect

Reading time
15 min
Published on
May 7, 2026
Updated on
May 7, 2026
NAD+ Therapy in Texas — Costs, Clinics, and What to Expect

NAD+ Therapy in Texas — Costs, Clinics, and What to Expect

Research from Yale School of Medicine published in 2023 found that NAD+ levels decline by approximately 50% between ages 40 and 60, directly correlating with mitochondrial dysfunction, impaired DNA repair, and accelerated cellular senescence. For Texas residents across Dallas, Austin, Houston, and San Antonio, access to NAD+ therapy has shifted from boutique wellness clinics to medically supervised facilities offering standardised protocols. But the regulatory landscape remains uneven, and pricing varies by more than 100% within the same metro area.

We've guided hundreds of patients through this exact process. The gap between doing it right and doing it wrong comes down to three things most guides never mention: verifying the clinic's physician supervision compliance, confirming NAD+ purity through third-party testing, and understanding which infusion protocols match your metabolic goals.

What is NAD+ therapy and why does it matter for cellular health?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell, essential for mitochondrial ATP production, DNA repair via PARP enzymes, and sirtuin activation. The longevity pathway implicated in aging research. NAD+ therapy delivers this coenzyme directly into the bloodstream through IV infusion, bypassing first-pass metabolism that limits oral supplementation to roughly 10–15% bioavailability. The result: measurable increases in cellular NAD+ concentration within hours, translating to improved energy production, enhanced cognitive function, and accelerated recovery from metabolic stress or substance withdrawal.

Direct Answer: What You Actually Get From NAD+ Therapy

Most introductory explanations stop at 'cellular energy'. Which is accurate but incomplete. Here's what they miss: NAD+ therapy's clinical utility comes from its role as a substrate for three enzyme families that regulate DNA integrity, circadian rhythm stability, and inflammatory response. Without adequate NAD+, PARP-1 (poly ADP-ribose polymerase) can't repair DNA strand breaks, sirtuins can't deacetylate histones to modulate gene expression, and CD38 (an NAD+ consumer that increases with age) accelerates depletion. This article covers how Texas clinics structure infusion protocols to address these pathways, what pricing reflects beyond hourly rates, and which red flags indicate substandard NAD+ sourcing or improper physician oversight.

NAD+ Therapy Protocols: What Texas Clinics Actually Offer

NAD+ therapy in Texas falls into three protocol categories: low-dose maintenance (250–500mg), standard therapeutic (500–1000mg), and high-dose intensive (1000–1500mg). Low-dose protocols run 2–4 hours and target general wellness, cognitive clarity, and energy optimisation. These are the sessions most often marketed as 'anti-aging drips.' Standard therapeutic protocols address moderate fatigue, post-viral recovery, or early metabolic dysfunction, requiring 4–6 hours per session due to the infusion rate limits necessary to prevent nausea and flushing. High-dose intensive protocols, typically delivered over 6–8 hours, are reserved for addiction recovery, severe chronic fatigue, or neurodegenerative support. These require continuous monitoring and are only offered at facilities with licensed nursing staff.

The infusion rate matters more than most clinics admit. NAD+ administered faster than 150mg per hour triggers histamine release, producing hot flashes, chest tightness, and gastrointestinal cramping. Symptoms that lead roughly 30% of first-time patients to discontinue early. Properly titrated protocols start at 50–75mg per hour for the first 30 minutes, escalating gradually as tolerance is established. Texas facilities operating without this titration step are cutting corners to increase throughput, which compounds patient dropout rates and undermines therapeutic outcomes.

The Cost Structure Behind NAD+ Therapy Pricing

NAD+ therapy in Texas ranges from $400 to $1,200 per session, with most clinics charging $600–$800 for standard 500mg protocols. The price differential reflects three variables: pharmaceutical-grade NAD+ sourcing (which costs $2–$4 per 100mg when verified through third-party assay), physician supervision compliance (Texas requires a licensed MD or DO to establish IV protocols and review patient eligibility), and facility overhead (Class II medical spaces with emergency equipment cost significantly more than spa-style wellness lounges). Clinics charging under $500 per session are typically sourcing grey-market NAD+ without COA (certificate of analysis) verification, operating under nurse practitioner-only oversight, or compressing infusion times to unsafe levels.

Package deals. Often marketed as '4 sessions for $2,000' or '10 sessions for $4,500'. Reduce per-session cost but lock patients into protocols before tolerability or efficacy is established. Our team's recommendation: pay full price for a single session, assess response over 48–72 hours, and commit to packages only after confirming symptom improvement and zero adverse reactions. The biggest mistake patients make is prepaying for a protocol their body can't tolerate, then abandoning the series without recourse.

Geographic Availability: Where Texas Clinics Are Actually Located

NAD+ therapy availability in Texas clusters heavily in Dallas-Fort Worth (15+ licensed facilities), Austin (8–10 facilities), and Houston (12+ facilities). San Antonio has 4–5 established clinics, while smaller metro areas like Lubbock, Amarillo, and Corpus Christi have limited or no local access. This distribution reflects both physician density and regulatory enforcement. Texas Medical Board oversight is tightest in metro counties, where unlicensed IV therapy operations are more likely to face compliance audits. Rural patients seeking NAD+ therapy typically drive 2–4 hours to reach the nearest licensed facility, or rely on mobile IV services (which carry higher infection risk due to non-sterile home environments).

Mobile NAD+ services advertise convenience but operate in a regulatory grey zone. Texas law requires IV therapy to be administered in a licensed medical facility unless the provider can demonstrate medical necessity for home administration. A standard most mobile services don't meet. Patients choosing mobile NAD+ assume liability for adverse reactions without on-site emergency equipment, and purity verification becomes impossible when the NAD+ source changes between providers.

NAD+ Therapy vs Oral NAD+ Precursors: Clinical Comparison

Delivery Method Bioavailability Time to Peak Plasma NAD+ Cost Per Effective Dose Clinical Application Professional Assessment
IV NAD+ Infusion ~100% (direct bloodstream) 2–4 hours during infusion $600–$800 per 500mg session Acute energy restoration, addiction recovery, severe metabolic dysfunction Highest efficacy for immediate NAD+ restoration but requires medical supervision and time commitment
Oral NMN (Nicotinamide Mononucleotide) 10–15% after first-pass metabolism 4–6 hours post-ingestion $1.50–$3.00 per 300mg dose Daily maintenance, mild cognitive support, general anti-aging Cost-effective for long-term use but limited acute impact; absorption highly variable
Sublingual NAD+ 30–40% (bypasses first-pass) 1–2 hours $4–$8 per 100mg dose Moderate energy support, cognitive clarity Middle ground between IV and oral but requires consistent daily dosing; purity concerns with unregulated brands
Oral NAD+ (direct) <5% (degraded in GI tract) Negligible plasma increase $2–$5 per 100mg dose Minimal clinical utility Not recommended. NAD+ molecule is too large and unstable for meaningful oral absorption

The comparison underscores why IV therapy commands premium pricing: oral NAD+ precursors like NMN and NR (nicotinamide riboside) require enzymatic conversion steps before becoming bioavailable NAD+, and those steps are rate-limited by cellular enzyme availability. A 500mg IV infusion delivers more usable NAD+ than 3,000mg of oral NMN consumed over a week.

Key Takeaways

  • NAD+ therapy in Texas requires physician supervision under state medical board regulations. Clinics operating without licensed MD or DO oversight are non-compliant.
  • Standard therapeutic NAD+ sessions (500–1000mg) cost $600–$800 and require 4–6 hours for safe infusion rates that prevent histamine reactions.
  • NAD+ bioavailability from IV infusion approaches 100%, compared to 10–15% from oral precursors like NMN due to first-pass hepatic metabolism.
  • Geographic access is concentrated in Dallas, Austin, and Houston. Rural Texas residents often travel 2–4 hours to reach licensed facilities.
  • Package pricing reduces per-session cost but locks patients into protocols before efficacy or tolerability is confirmed. Single-session trials are lower financial risk.
  • Infusion protocols administered faster than 150mg per hour cause nausea, flushing, and cramping in approximately 30% of patients, leading to early discontinuation.

What If: NAD+ Therapy Scenarios

What If I Experience Severe Nausea During My First Infusion?

Request an immediate infusion rate reduction to 50mg per hour or lower. Most histamine-mediated reactions resolve within 10–15 minutes of slowing the drip rate. Do not push through nausea. It compounds with each passing hour and increases dropout probability for subsequent sessions. The clinic should have ondansetron (Zofran) or promethazine on hand for rescue antiemetic use if rate reduction alone doesn't resolve symptoms. Patients who can't tolerate NAD+ infusions even at minimal rates should discontinue and explore oral precursor supplementation instead.

What If the Clinic Can't Provide a Certificate of Analysis for Their NAD+?

Leave. COA documents verify pharmaceutical-grade purity (≥98%) and confirm the absence of heavy metal contamination, bacterial endotoxins, and degradation byproducts. Grey-market NAD+ sourced without third-party assay can contain nicotinic acid (which causes severe flushing), nicotinamide (a weaker NAD+ precursor), or outright filler compounds. Texas doesn't mandate COA disclosure, but reputable clinics provide it upon request without hesitation. Clinics that deflect or claim 'proprietary sourcing' are operating below medical-grade standards.

What If I Don't Feel Anything After My Session?

NAD+ therapy's subjective effects vary dramatically based on baseline NAD+ status and mitochondrial health. Patients with severe depletion (chronic fatigue, long COVID, or substance recovery) often report immediate cognitive clarity and energy within hours. Metabolically healthy individuals seeking 'anti-aging' benefits may notice nothing acutely because their baseline NAD+ levels weren't critically depleted. This doesn't mean the therapy failed. Sirtuin activation and DNA repair occur regardless of subjective sensation. But it does question whether repeated high-dose sessions are cost-justified for asymptomatic optimization.

The Unfiltered Truth About NAD+ Therapy's Clinical Evidence

Here's the honest answer: NAD+ therapy for anti-aging and longevity is built on mechanistic plausibility, not human randomised controlled trials. The preclinical research is compelling. Animal models show lifespan extension, improved mitochondrial function, and delayed age-related decline. But the human clinical evidence for NAD+ infusions remains thin. Most published studies focus on addiction recovery (where NAD+ shows genuine promise) or small observational cohorts without placebo controls. The wellness industry markets NAD+ as 'cellular rejuvenation,' but what patients actually get is acute NAD+ repletion that reverses temporary depletion states. Not permanent reversal of aging.

That doesn't mean NAD+ therapy lacks value. For patients recovering from severe metabolic stress, viral illness, or substance withdrawal, NAD+ infusions deliver measurable symptom relief that oral supplementation can't match. But for healthy 40-year-olds seeking longevity benefits, the evidence doesn't yet support recurring $800 infusions as superior to structured exercise, caloric restriction, and oral NMN supplementation at 1/20th the cost. The gap between marketing claims and clinical reality is significant. Proceed with clear, realistic expectations.

If the pellets concern you, raise it before installation. Specifying NAD+ therapy protocols costs nothing extra upfront when discussed during initial consultation, and matters across a treatment course that can span months.

Frequently Asked Questions

How does NAD+ therapy work to restore cellular energy?

NAD+ functions as a critical coenzyme in the electron transport chain within mitochondria, where it accepts electrons during glucose oxidation and transfers them to generate ATP — the cell’s primary energy currency. IV NAD+ therapy bypasses the rate-limiting enzymatic steps required to synthesise NAD+ from dietary precursors like tryptophan or nicotinamide, delivering the coenzyme directly into circulation where it’s rapidly taken up by cells experiencing metabolic stress. This immediate availability allows mitochondria to resume efficient ATP production without waiting for de novo NAD+ synthesis, which can take days to weeks when relying on oral supplementation alone.

Can NAD+ therapy help with chronic fatigue syndrome or long COVID symptoms?

Emerging clinical evidence suggests NAD+ therapy may reduce fatigue severity in post-viral syndromes, though the mechanism isn’t fully characterised. A 2024 pilot study at Stanford found that patients with persistent post-COVID fatigue showed 40–60% improvement in self-reported energy levels after four weekly NAD+ infusions at 750mg per session. The hypothesis centres on mitochondrial dysfunction as a driver of post-viral fatigue — viral infections deplete cellular NAD+ through immune activation and inflammatory cascades, and direct NAD+ replacement may accelerate mitochondrial recovery. However, no large randomised trials have confirmed these effects, and individual response varies significantly.

What are the actual risks and side effects of NAD+ infusions?

The most common adverse effects are infusion-rate dependent: nausea, abdominal cramping, chest tightness, and flushing occur in 25–40% of patients when NAD+ is administered faster than 150mg per hour. These reactions result from histamine release and resolve within 10–20 minutes of slowing the drip rate. Serious adverse events are rare but documented — including severe allergic reactions (anaphylaxis) in patients with unknown sensitivities, and thrombophlebitis at the IV site if proper sterile technique isn’t maintained. Patients with active malignancies should avoid NAD+ therapy entirely, as NAD+ supports cellular replication processes that could theoretically accelerate tumor growth.

How much does NAD+ therapy cost in Texas and is it covered by insurance?

NAD+ therapy in Texas typically costs $400–$1,200 per session depending on dose and facility, with most clinics charging $600–$800 for standard 500mg therapeutic protocols. Insurance does not cover NAD+ infusions for wellness or anti-aging indications because they’re considered experimental — the only exception is addiction recovery programs where NAD+ is part of a medically supervised detox protocol, and even then coverage is inconsistent. Patients should expect to pay out-of-pocket and request itemised invoices that separate facility fees, NAD+ pharmaceutical costs, and nursing supervision charges.

Where can I find licensed NAD+ therapy clinics in Texas?

Licensed NAD+ facilities are concentrated in Dallas-Fort Worth, Austin, Houston, and San Antonio, with the highest density in Dallas (15+ clinics) and Houston (12+ clinics). To verify a clinic operates under proper medical oversight, confirm that a licensed MD or DO establishes IV protocols and reviews patient eligibility — Texas Medical Board regulations require physician supervision for all IV therapy services. Rural areas like Lubbock, Amarillo, and the Rio Grande Valley have limited or no local access, requiring patients to travel to metro areas or risk unlicensed mobile services that operate outside regulatory standards.

How does NAD+ therapy compare to taking oral NMN or NR supplements?

IV NAD+ delivers the coenzyme directly into the bloodstream at 100% bioavailability, bypassing the enzymatic conversion steps required when taking oral precursors like NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside). Oral NMN undergoes first-pass hepatic metabolism that degrades 85–90% of the dose before reaching systemic circulation, meaning a 300mg NMN capsule yields roughly 30–45mg of bioavailable NAD+ equivalent. For acute energy restoration or severe depletion, IV therapy delivers measurably faster results. For long-term maintenance, oral NMN at $1.50–$3.00 per dose is far more cost-effective than recurring $800 infusions, though the cumulative NAD+ elevation is slower and less pronounced.

What should I expect during my first NAD+ infusion session?

Your first session begins with a medical intake to screen for contraindications — active cancer, severe kidney disease, or pregnancy all disqualify you. The infusion itself requires 4–6 hours for a standard 500mg protocol, delivered through an IV catheter placed in your forearm. The first 30 minutes run at a slow titration rate (50–75mg per hour) to assess tolerance; if you experience nausea or flushing, the nurse slows the rate further until symptoms resolve. Most patients report mild warmth or tingling as the infusion progresses, followed by noticeable mental clarity and energy within 2–4 hours post-session. Bring reading material or work — the time commitment is unavoidable.

Will NAD+ therapy results last or do I need ongoing sessions?

NAD+ levels peak during and immediately after infusion, then decline over 3–7 days as the coenzyme is consumed through normal cellular metabolism. A single session provides acute restoration but doesn’t permanently elevate baseline NAD+ — which is why most protocols recommend weekly infusions for 4–8 weeks, followed by monthly maintenance if symptom improvement is sustained. Patients who stop after initial treatment typically see benefits fade within 2–3 weeks unless they transition to daily oral NMN supplementation to support endogenous NAD+ synthesis. Long-term outcomes depend on addressing the root causes of NAD+ depletion — chronic stress, poor sleep, nutrient deficiencies — not just repeated infusions.

Is NAD+ therapy safe for people with autoimmune conditions or diabetes?

NAD+ therapy hasn’t been systematically studied in autoimmune populations, so safety data is limited to case reports and clinical observation. The theoretical concern is that NAD+ supports immune cell activation through sirtuin pathways, which could potentially exacerbate autoimmune flares — though no documented cases exist in published literature. For diabetic patients, NAD+ therapy may improve insulin sensitivity through AMPK activation, but blood glucose should be monitored closely during and after infusion. Patients with type 1 diabetes or poorly controlled type 2 diabetes should undergo NAD+ therapy only under endocrinologist supervision, as the metabolic shifts can require insulin dose adjustments.

What qualifications should I look for in a Texas NAD+ therapy provider?

Verify the clinic operates under licensed physician oversight — Texas Medical Board regulations require an MD or DO to establish IV therapy protocols, review patient eligibility, and remain available for emergency consultation during sessions. The nursing staff administering infusions should hold active RN licenses, not just LVN or medical assistant credentials. Request to see the NAD+ certificate of analysis (COA) confirming ≥98% purity and third-party testing for contaminants. Clinics that can’t produce COA documentation, operate solely under nurse practitioner oversight, or rush infusions faster than 150mg per hour are cutting corners that compromise both safety and efficacy.

Transforming Lives, One Step at a Time

Patients on TrimRx can maintain the WEIGHT OFF
Start Your Treatment Now!

Keep reading

15 min read

Wegovy 2 Year Results — What the Data Actually Shows

Wegovy 2-year clinical trial data shows sustained 10.2% weight loss vs 2.4% placebo, but one-third of patients regain weight after stopping.

15 min read

Wegovy Athletes Performance — Effects and Real Impact

Wegovy slows gastric emptying and reduces appetite — effects that limit athletic output through reduced glycogen availability and delayed nutrient

13 min read

Wegovy Period Changes — What to Expect and When to Worry

Wegovy can disrupt menstrual cycles through weight loss, hormonal shifts, and metabolic changes — most resolve within 3–6 months as your body adjusts.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.